InspireMD (NSPR)

InspireMD's (NSPR) CEO Jim Barry on Q1 2018 Results - Earnings Call Transcript
May 7, 2018 | Price: Free! | Source: Seeking Alpha

InspireMD's (NSPR) CEO Jim Barry on Q3 2017 Results - Earnings Call Transcript
Nov. 8, 2017 | Price: Free! | Source: Seeking Alpha

InspireMD's (NSPR) CEO Jim Barry on Q1 2017 Results - Earnings Call Transcript
May 12, 2017 | Price: Free! | Source: Seeking Alpha

InspireMD's (NSPR) CEO Alan Milinazzo on Q3 2015 Results - Earnings Call Transcript
Nov. 10, 2015 | Price: Free! | Source: Seeking Alpha

InspireMD's (NSPR) CEO Alan Milinazzo on Q2 2015 Results - Earnings Call Transcript
Aug. 5, 2015 | Price: Free! | Source: Seeking Alpha

InspireMD's (NSPR) CEO Alan Milinazzo on Q1 2015 Results - Earnings Call Transcript
May 11, 2015 | Price: Free! | Source: Seeking Alpha

InspireMD's (NSPR) CEO Alan Milinazzo on Q4 2014 Results - Earnings Call Transcript
March 12, 2015 | Price: Free! | Source: Seeking Alpha

InspireMD's CEO Discusses Q3 2013 Results - Earnings Call Transcript
Nov. 13, 2013 | Price: Free! | Source: Seeking Alpha

Inspiremd Inc - Q3 2013 Earnings Call Transcript
Nov. 11, 2013 | Price: Free! | Source: Earnings Impact

InspireMD Inc - Business Update Transcript
Oct. 30, 2013 | Price: Free! | Source: Earnings Impact

Recent filings

InspireMD Just Filed Its Quarterly Report: NOTE 10 – SUBSEQUEN... - May 7, 2018

InspireMD: In India And Peru - May 7, 2018

Inspiremd’S Cguard™ Embolic Prevention System To Be Featured At Icca Stroke 2018 In Warsaw, Poland - April 19, 2018

Statement of acquisition of beneficial ownership by individuals - April 9, 2018

Inspiremd Anticipates Fifth Consecutive Quarter Of Sequential Double Digit Growth; - April 3, 2018

Martin D. Hoe just provided an update on share ownership of InspireMD - April 3, 2018

Entry into a Material Definitive - April 3, 2018

Inspiremd, Inc. Announces Proposed Public Offering Of Common Stock - March 29, 2018

InspireMD just filed a prospectus, suggesting it plans to soon issue some securities - March 29, 2018

InspireMD just filed a prospectus, suggesting it plans to soon issue some securities - March 28, 2018

On March - March 27, 2018

InspireMD Just Received a Notice of Effectiveness - March 14, 2018

Registration statement under Securities Act of 1933 - March 8, 2018

Inspiremd Announces First Patient Treated With Cguard - March 5, 2018

Inspiremd Announces Expansion Of Its Distribution Network - March 1, 2018

InspireMD just filed a prospectus, suggesting it plans to soon issue some securities - Feb. 26, 2018

Inspiremd, Inc. Announces Proposed Public Offering Of Common Stock - Feb. 26, 2018

InspireMD Just Received a Notice of Effectiveness - Feb. 23, 2018

InspireMD: Nspiremd Announces Exclusive Distribution, Sales And Marketing Agreement For Cguard™ Eps In South Korea - Feb. 22, 2018

Registration statement under Securities Act of 1933 - Feb. 21, 2018

Entry into a Material Definitive - Feb. 21, 2018

Inspiremd Announces Commercial Launch - Feb. 20, 2018

Inspiremd Announces Fourth Quarter And Year-End 2017 Results; - Feb. 14, 2018

Renaissance Technologies LLC just provided an update on share ownership of InspireMD - Feb. 14, 2018

Inspiremd Announces 1-For-35 Reverse Stock Split - Feb. 7, 2018

Inspiremd’S Cguard™ Embolic Prevention System - Feb. 1, 2018

InspireMD's President and CEO just disposed of 11 shares - Jan. 29, 2018

Inspiremd’S Cguard™ Embolic Prevention System - Jan. 26, 2018

Inspiremd Announces Publication Of An Independent Imaging Study - Jan. 19, 2018

InspireMD: Jim Barry, Craig Shore From: David Waldman, Natalya Rudman Business Update Call - Jan. 10, 2018

Results of Operations and Financial - Jan. 10, 2018

InspireMD: Financial Statements And Exhibits - Jan. 10, 2018

InspireMD: Item 8.01 Other Events - Jan. 8, 2018

Inspiremd Announces Regulatory Approval Of Cguard™ Eps In India; - Jan. 8, 2018

Inspiremd Schedules Conference Call To Discuss Recent Developments, Preliminary Sales Results And Proposals For Upcoming Shareholder Meeting - Jan. 8, 2018

Other definitive proxy statements - Dec. 26, 2017

Material Modification to Rights of Security - Dec. 22, 2017

Inspiremd’S Cguard™ Embolic Prevention System Once Again Featured In A - Dec. 18, 2017

Preliminary Proxy Soliciting materials - Dec. 15, 2017

Sabby Healthcare Master Fund, Ltd. just provided an update on share ownership of InspireMD - Dec. 14, 2017

Material Modification to Rights of Security - Dec. 12, 2017

Notice of Exempt Offering of Securities, item 06b - Dec. 12, 2017

Entry into a Material Definitive - Dec. 8, 2017

InspireMD: Paradigm Clinical Study Using Cguard™ Eps - Dec. 5, 2017

Other preliminary proxy statements - Dec. 5, 2017

Material Modification to Rights of Security - Dec. 4, 2017

Inspiremd Announces Expansion Of Its Distribution Network - Dec. 4, 2017

Inspiremd Announces Planned Recapitalization - Nov. 29, 2017

Inspiremd Announces Third Quarter 2017 Results; - Nov. 7, 2017

InspireMD Just Filed Its Quarterly Report: NOTE 6- NET LOSS PE... - Nov. 7, 2017

Submission of Matters to a Vote of Security - Oct. 31, 2017

New York Stock Exchange Accepts Inspiremd’S Plan To Regain Compliance - Oct. 25, 2017

InspireMD: Investigator Initiated Trial Of Cguard™ Eps In Russia - Oct. 10, 2017

InspireMD: Item 8.01 Other Events - Oct. 4, 2017

Inspiremd Postpones Special Meeting - Oct. 4, 2017

Inspiremd Announces Distribution Agreement - Sept. 21, 2017

Regulation FD - Sept. 12, 2017

Departure of Directors or Certain - Sept. 7, 2017

InspireMD releases salary data. CEO sees compensation rise 86% - Aug. 29, 2017

Inspiremd Announces Distribution Agreement - Aug. 25, 2017

InspireMD: From European Key Opinion Leaders - Aug. 22, 2017

Other preliminary proxy statements - Aug. 18, 2017

InspireMD Just Filed Its Quarterly Report: NOTE 6- NET LOSS PE... - Aug. 8, 2017

Inspiremd Reports Double Digit Sequential And Year-Over-Year Revenue Growth For The Second Quarter Of 2017 - Aug. 8, 2017

Inspiremd Announces Publication Of An Independent Clinical Review Authored By Leading U.S. And European Physicians Supporting Safety Advantages Of Mesh-Covered Carotid Stents - Aug. 7, 2017

Inspiremd’S Cguard™ Carotid Embolic Prevention System - Aug. 4, 2017

InspireMD's President and CEO just disposed of 22,942 shares - Aug. 2, 2017

Submission of Matters to a Vote of Security - June 29, 2017

Regulation FD - June 15, 2017

Inspiremd Announces Completion Of Transition From Exclusive European - June 13, 2017

Inspiremd Announces Distribution Agreement For Cguard™ Eps In Taiwan - June 8, 2017

Inspiremd Announces The Publication Of An Investigator Initiated Clinical Registry Reaffirming Mguard - June 7, 2017

Inspiremd Announces Distribution Agreement - June 5, 2017

InspireMD: Paul Stuka As Chairman Of The Board - June 2, 2017

InspireMD: Item 5.02 Departure Of Directors Or Principal Officers; Election Of Directors; Appointment Of Principal Officer - June 2, 2017

Inspiremd Announces First Two Patients In Hong Kong - May 31, 2017

Inspiremd’S Cguard™ Carotid Embolic Prevention System - May 18, 2017

InspireMD: Iron-Guard Registry In Eurointervention - May 17, 2017

Inspiremd Announces Distribution Agreements For Cguard™ Eps And Mguard Prime™ Eps In Peru And Ecuador - May 15, 2017

Additional definitive proxy soliciting materials and Rule 14(a)(12) material - May 10, 2017

InspireMD releases salary data. CEO sees compensation rise 86% - May 10, 2017

Inspiremd Provides Business Update For The First Quarter Of 2017 - May 9, 2017

InspireMD Just Filed Its Quarterly Report: NOTE 6- NET LOSS PE... - May 9, 2017

Inspiremd Announces Distribution Agreement - May 1, 2017

Shareholder Director - April 26, 2017

Inspiremd Announces Listing Of Series B Warrants - April 6, 2017

InspireMD just filed a paper-based report - April 4, 2017

Registration of securities [Section 12(b)] - April 4, 2017

InspireMD: Russian Federation At The Icca Stroke Event In Moscow - March 30, 2017

Current report, items 7.01 and 9.01 - March 29, 2017

Inspiremd Repays Term Note Ahead Of Schedule - March 22, 2017

InspireMD: Distribution Agreement For The Russian Federation - March 21, 2017

Inspiremd Announces Closing Of Public Offering - March 15, 2017

InspireMD just filed a prospectus, suggesting it plans to soon issue some securities - March 10, 2017

On March - March 9, 2017

General form for registration of securities under the Securities Act of 1933 - March 8, 2017

InspireMD Just Received a Notice of Effectiveness - March 8, 2017

General form for registration of securities under the Securities Act of 1933 - March 7, 2017

General form for registration of securities under the Securities Act of 1933 - March 6, 2017

General form for registration of securities under the Securities Act of 1933 - Feb. 23, 2017

Sorry, no schedule available for this company

Owner Shares% of PortfolioAs Of
1. SABBY MANAGEMENT, LLC 7,519,227 N/A Dec. 31, 2017
2. Sol J. Barer 2,085,046 N/A March 31, 2016
3. KCG Holdings, Inc. 314,135 N/A June 30, 2017
4. Frigate Ventures LP 312,500 N/A Sept. 30, 2017
5. TWO SIGMA SECURITIES, LLC 168,029 N/A Dec. 31, 2017
6. UBS Group AG 98,198 N/A Dec. 31, 2017
7. SUSQUEHANNA INTERNATIONAL GROUP, LLP 93,748 N/A Dec. 31, 2017
8. Keel Point, LLC 83,927 0.3 March 31, 2018
9. Virtu Financial LLC 38,400 N/A March 31, 2018
10. JANE STREET GROUP, LLC 21,763 N/A March 31, 2018
11. PANAGORA ASSET MANAGEMENT INC 20,947 N/A March 31, 2018
12. GOLDMAN SACHS GROUP INC 15,669 N/A Sept. 30, 2017
13. Bank of New York Mellon Corp 12,482 N/A Dec. 31, 2016
14. Citadel Advisors LLC 10,127 N/A Sept. 30, 2017
15. Platinum Management (NY) LLC 2,445 N/A March 31, 2016
16. BlackRock Fund Advisors 1,238 N/A Sept. 30, 2016
17. Ground Swell Capital, LLC 281 N/A June 30, 2014
18. MORGAN STANLEY 83 N/A Dec. 31, 2016
19. Sabby Healthcare Master Fund, Ltd. 0 N/A Dec. 31, 2015

InspireMD (NSPR)

140
 


Feedback